News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘BreastCancer’ clear

  • Ursula Matulonis, MD, and colleagues report a two-drug combination that disrupts critical signaling circuits in cancer cells has produced an observable benefit in patients with recurrent high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC).

Tags: BreastCancer, CervicalCancer

  • Using a novel three-part screening process, scientists at Dana-Farber Cancer Institute have identified a gene that is made inappropriately in about a third of all breast cancers. The discovery, reached in collaboration with researchers at Brigham and Womens Hospital (BWH) and the Broad Institute of Harvard and MIT, is reported in the June 15, 2007, issue of the journal Cell.

Tags: BasicResearch, BreastCancer

  • In a new study, women with relatively small, HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted therapy following surgery or radiation therapy were very unlikely to have the cancer recur within a few years of treatment.

Tags: chemotherapy, BreastCancer, TargetedTherapy

  • Dana-Farber has opened a mammography suite within the Whittier Street Health Center, located in Boston's Roxbury neighborhood.

Tags: BreastCancer, Disparities, Imaging

  • Erica Mayer, MD, MPH, is a breast cancer expert at Dana-Farber. She says there are at least five simple ways women can reduce their risk of getting the disease.

Tags: BreastCancer, Genetics, Prevention

  • Breast cancer risk and prevention experts comment on new guidelines suggesting women ages 40 to 49 do not need regular breast cancer screenings.

Tags: BreastCancer

  • Practice-changing clinical research conducted at the Dana-Farber Cancer Institute Department of Biostatistics and Computational Biology was featured at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting Plenary Session.

Tags: BreastCancer, ProstateCancer

  • Kornelia Polyak, MD, PhD, and colleagues identified a network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors.

Tags: BreastCancer, Genomics

  • Younger women are more likely to be diagnosed with later-stage breast cancer, and treatment may affect fertility. Dana-Farber's specialized program addresses the unique needs of these patients.

Tags: BreastCancer

  • Susan G. Komen for the Cure, the world's largest grassroots network of breast cancer survivors and activists, has announced the appointment of Eric P. Winer, MD, a nationally known medical oncologist, researcher and educator from the Dana-Farber Cancer Institute and Harvard Medical Center, as its chief scientific advisor.

Tags: BreastCancer

Showing 11-20 of 46 items